Skip to content

Discover cytogenetics without the bottlenecks

AACR 2025 Sarcoma Poster Figure-1

Genomic Proximity Mapping™ (GPM) extends cytogenetic profiling to all cancer types and sample formats in a single, short read sequencing-based assay. 

This year at AACR, researchers benchmarked GPM against standard-of-care cytogenetic diagnostics in FFPE sarcoma tissue, finding that it:

  • Detected pathognomonic gene fusions missed by standard-of-care FISH and anchored multiplex PCR (AMP)
  • Identified novel—and potentially disease-defining—genomic aberrations 
  • Located rare gene fusions pointing to novel therapeutic options

Complete the form to access the full takeaways and a slice of the possibility GPM is unlocking in molecular diagnostics.